Brand-name drug · guanylate cyclase-C agonist
Linzess (linaclotide)
From the FDA label, read Published by PepVault
Linzess is linaclotide, a small peptide taken as a once-daily capsule, marketed by AbbVie with Ironwood Pharmaceuticals. It works inside the gut, where it draws salt and water into the bowel.
FDA approved it for irritable bowel syndrome with constipation (IBS-C) in adults and children 7 and older, for chronic idiopathic constipation (CIC) in adults, and for functional constipation in children 2 and older.
- Active ingredient
- Linaclotide
- Maker
- AbbVie
- Class
- guanylate cyclase-C agonist
- FDA application
- NDA 202811, first approved 2012
What FDA approved it for
IBS-C is belly pain together with infrequent, hard stools. Chronic idiopathic constipation is long-lasting constipation with no cause found, and functional constipation is the same picture in a child.
In an animal model of gut pain, linaclotide also quieted pain-sensing nerves, a finding from animals that the label reports beside its main action.
From the label: 12.1 Mechanism of Action; 1 Indications and Usage.
How it is supplied
| Form | Doses |
|---|---|
| Capsule | 72 mcg, 145 mcg, 290 mcg |
From the label: 3 Dosage Forms and Strengths.
The label’s dosing schedule
This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.
IBS-C in adults, once a day
| Dose | When, on the label |
|---|---|
| 290 mcg a day | Every day, at least 30 minutes before a meal |
IBS-C in children 7 and older, once a day
| Dose | When, on the label |
|---|---|
| 145 mcg a day | Every day, at least 30 minutes before a meal |
Chronic idiopathic constipation in adults, once a day
| Dose | When, on the label |
|---|---|
| 145 mcg a day | Every day; 72 mcg a day is the label’s lower option |
For chronic constipation, the label’s dose is 145 mcg, with 72 mcg a day as an option chosen by how a person’s symptoms present or how well they handle it.
Functional constipation in children 2 and older, once a day
| Dose | When, on the label |
|---|---|
| 72 mcg a day | Every day, at least 30 minutes before a meal |
Every schedule is one capsule a day with no climb; the strength is set by the condition and the age. A child with IBS-C takes the 145 mcg capsule, half the adult’s 290 mcg.
From the label: 2.1 Recommended Dosage.
How it’s taken
A Linzess capsule is taken on an empty stomach, at least 30 minutes before a meal, at about the same time each day. It is swallowed whole, never crushed or chewed.
For someone who can’t swallow capsules, the label lets the capsule be opened and its beads taken at once in a teaspoon of applesauce or in about 30 mL of water, or given with water through a feeding tube. The beads themselves don’t dissolve, and the medicine washes off them.
From the label: 2.2 Preparation and Administration Instructions.

If a dose is missed
A missed Linzess dose is skipped, and the next one is taken at the regular time; the label says never to take two doses together.
From the label: 2.2 Preparation and Administration Instructions.
Storage
Linzess is kept at room temperature, around 77°F, in its original bottle, tightly closed, with the moisture-absorbing packet left inside. The capsules are not moved to a pill organizer or another container.
From the label: 16 How Supplied/Storage and Handling.
Side effects and warnings
| Reaction | Placebo | 290 mcg |
|---|---|---|
| Diarrhea | 3 | 20 |
| Belly pain | 5 | 7 |
| Gas (flatulence) | 2 | 4 |
| Headache | 3 | 4 |
| Stomach flu (viral gastroenteritis) | 1 | 3 |
| Bloating (abdominal distension) | 1 | 2 |
Diarrhea was the most common reaction, in 20% against 3% on placebo, and most cases began in the first 2 weeks. It was severe in 2%, and 5% stopped Linzess because of it.
In children, diarrhea was again the most common reaction: 7% on 145 mcg in the IBS-C trial of ages 7 to 17, and 4% on 72 mcg in the functional constipation trial of ages 6 to 17.
The boxed warning
The other warnings
Its other warning is diarrhea: if it becomes severe, the label pauses the dose and replaces lost fluids, since severe cases with dizziness, fainting or low salts in the blood have needed hospital care. Linzess is also not used when the bowel is, or may be, blocked.
From the label: 6.1 Clinical Trials Experience; 5.2 Diarrhea; Boxed Warning; 5 Warnings and Precautions.
What else we have on linaclotide
Linaclotide on PepVault
Free tools
Questions about Linzess
What is the dose of Linzess?
It depends on the condition: 290 mcg once a day for adults with IBS-C, 145 mcg (or 72 mcg) for adults with chronic idiopathic constipation, 145 mcg for children 7 and older with IBS-C, and 72 mcg for children 2 and older with functional constipation. A prescriber picks the strength.
When should Linzess be taken?
On an empty stomach, at least 30 minutes before a meal, at about the same time each day, swallowed whole.
What if a Linzess dose is missed?
Skip it and take the next one at the regular time; the label says not to take two doses together.
What is the most common side effect of Linzess?
Diarrhea: 20% of adults with IBS-C on Linzess against 3% on placebo, usually starting in the first 2 weeks.
Can children take Linzess?
From age 2 for functional constipation and from age 7 for IBS-C. It is never given to children under 2, the subject of its boxed warning.
Can a Linzess capsule be opened?
Yes, for someone who can’t swallow it: the beads can be taken right away in a teaspoon of applesauce or in water, or given through a feeding tube. They are not chewed.
Sources
- LINZESS (linaclotide) capsules, for oral use, FDA label on DailyMed (version 40, published Oct 19, 2026; read Nov 18, 2026)
- Drugs@FDA, NDA 202811 (Linzess, the capsules; application first approved 2012)
PepVault is not affiliated with AbbVie. Linzess is a trademark of its owner.